IXHL
Incannex Healthcare Limited
IXHL • NASDAQ
Incannex Healthcare Limited is a pharmaceutical preparations company trading on NASDAQ, led by CEO Joel Bradley Latham.
CEOJoel Bradley Latham
Next Earnings
Upcoming earnings announcement for Incannex Healthcare Limited
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q3 2026
EPS Estimate
-$0.74
Revenue Estimate
$80.0K
Earnings History
Past 7 earnings reports for Incannex Healthcare Limited
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Q2 2026 | -$0.02Est: -$0.03 | +33.3% | -Est: $80.0K | -100.0% |  10-Q |
| Nov 14, 2025 | Q1 2026 | -$0.02Est: -$0.52 | +96.2% | -Est: $265.4K | -100.0% | 10-Q |
| May 15, 2025 | Q3 2025 | -$0.20 | — | - | — | 10-Q |
| Feb 14, 2025 | Q2 2025 | -$0.33 | — | $12.0K | — | 10-Q |
| Nov 14, 2024 | Q1 2025 | -$0.29 | — | $74.0K | — | 10-Q |
| Sep 30, 2024 | Q4 2024 | -$0.39 | — | $12.0K | — | 10-K |
| May 15, 2024 | Q3 2024 | -$0.38 | — | - | — | 10-Q |